Search
Zentalis Pharmaceuticals Inc
ZNTLAdd to Watchlist
3.700USD
+0.080+2.21%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
263.39MMarket Cap
LossP/E TTM
Zentalis Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Zentalis Pharmaceuticals Inc is 6.64, ranking 313 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.13, which is -84.50% below the recent high of -0.33 and -232.59% above the recent low of -7.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
